Sucralfate: A help during oral management in patients with epidermolysis bullosa

Journal of Periodontology

Volumn 72, Issue 5, 2001, Pages 691-695

  Marini, Ida ^a,b   Vecchiet, Federico ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE   (Italy)

Author keywords

Dental caries prevention and control; Epidermolysis bullosa; Oral hygiene methods; Sucralfate therapeutic use

Indexed keywords

SUCRALFATE;

ARTICLE; BLISTER; CHILD; CLINICAL ARTICLE; DENTAL CARIES; DRUG EFFICACY; EPIDERMOLYSIS BULLOSA; FEMALE; GENETIC DISORDER; HUMAN; MALE; MOUTH HYGIENE; PROPHYLAXIS; TOOTH PLAQUE;

ANTI-ULCER AGENTS; BLISTER; CHILD; COST-BENEFIT ANALYSIS; DENTAL CARIES; DENTAL PLAQUE INDEX; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FEMALE; HUMANS; MALE; MOUTH DISEASES; MOUTH MUCOSA; ORAL HYGIENE; PAIN; PAIN MEASUREMENT; PERIODONTAL INDEX; SUCRALFATE; SUSPENSIONS;

EID: 0034999790     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2001.72.5.691     Document Type: Article

References (37)

1. Coulombe P, Hutton ME, Letai A, Hebert A, Paller AS, Fuchs E. Point mutations in human 14 genes of epidermolysis bullosa simplex patients. Genetic and functional analysis. Cell 1991;66:1301-1311.
2. Gedde-Dahl T Jr. Epidermolysis Bullosa: A Clinical, Genetic and Epidemiologic Study. Baltimore: John Hopkins Press; 1971:119-135.
3. Gedde-Dahl T, Anton-Lamprecht I. Epidermolysis bullosa. In: Emery AEH, Rimoin DL, eds. Principles and Practice in Medical Genetics. New York: Churchill-Livingstone; 1990:855-876.
4. Bruckner-Tuderman L, Rantala I, Reunala T. Evidence for a structural abnormality of collagen VII in a patient with dystrophic epidermolysis bullosa inversa. J Invest Dermatol 1992;98:141-146.
5. Fine JD, McGrath J, Eady RAJ. Inherited epidermolysis bullosa comes into the new millenium: A revised classification system based on current knowledge of pathogenetic mechanisms and the clinical, laboratory, and epidemiologic findings of large, well-defined patients cohorts. J Am Acad Dermatol 2000;43:135-137.
6. Fine JD, Eady RAJ, Baner EA, et al. Revised classification system for inherited epidermolysis bullosa: report of the second international consensus meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol 2000;42:1051-1066.
7. Hashimoto I, Gedde-Dahl T Jr, Schnyder VW, Anton-Lamprecht I. Ultrastructural studies of epidermolysis bullosa hereditaria. IV. Recessive dystrophic types with junctional blistering. Arch Dermatol Res 1976;57:17-32.
8. Fine JD, Johnson L. Efficacy of systemic phenytoin in the treatment of junctional epidermolysis bullosa. Arch Dermatol 1988;124:1402-1406.
9. Kirkham J, Robinson C, Strafford SM, et al. The chemical composition of tooth enamel in recessive dystrophic epidermolysis bullosa: Significance with respect to dental caries. J Dent Res 1996;75:1672-1678.
10. Ulitto J, Christiano AM. Molecular basis for the dystrophic forms of epidermolysis bullosa: Mutations in the type VII collagen gene. Arch Dermatol Res 1994; 287:16-22.
11. Kivirikko S, McGrath JA, Baudoin C, et al. A homozygous nonsense mutation in the α3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Hum Mol Genet 1995;4:959-962.
12. Aberdam D, Galliano MF, Vailly J, et al. Herlitz' junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the y2 subunit of nicein/kalinin (laminin-5). Nat Genet 1994;6:299-304.
13. Pulkkinen L, Christiano AM, Airenne T, Haakana H, Tryggvason K, Ulitto J. Mutations in the y2 chain gene (LAMC2) of kalinin/laminin-5 in the junctional forms of epidermolysis bullosa. Nat Genet 1994;6:293-298.
14. Pulkkinen L, Christiano AM, Gerecke DR. A homozygous nonsense mutation in the β3 chain gene of laminin 5 (LAMB3) in Herlitz's junctional epidermolysis bullosa. Genomics 1994;24:357-360.
15. Wright JT, Fine JD, Johnson L. Dental caries risk in hereditary epidermolysis bullosa. Pediatr Dent 1994;16: 427-432.
16. Nowak AJ. Oropharyngeal lesions and their management in epidermolysis bullosa. Arch Dermatol 1988; 124:742-745.
17. Wright JT, Fine JD, Johnson LB, Steinmetz TT. Oral involvement of recessive dystrophic epidermolysis bullosa inversa. Am J Med Gen 1993;47:1184-1188.
18. Barker G, Loftus L, Cuddy P, Barker B. The effects of sucralfate suspension and diphenhydramine syrup plus kaolin pectin on radiotherapy-induced mucositis. Oral Surg Oral Med Oral Pathol 1991;71:288-293.
19. Verdi CJ. Cancer therapy and oral mucositis. An appraisal of drug prophylaxis. Drug Saf 1993;9:185-195.
20. Epstein JB, Wong FL. The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy, Int J Radiat Oncol Biol Phys 1994;28: 693-698.
21. Campisi G, Spadari F, Salvato A. Sucralfate in odontostomatology. Clinical experience. Min Stomatol 1997; 46:297-305.
22. Cenzig M, Ozyar E, Ozturk D, Akyol F, Atahan IL, Hayran M. Sucralfate in the prevention of radiation induced oral mucositis. J Clin Gastroenterol 1999;28: 40-43.
23. McCarthy DM. Sucralfate. New Engl J Med 1991;325: 1017-1025.
24. Scott J, Huskisson EG. Graphic representation of pain. Pain 1976;2:175-184.
25. Silness J, Löe H. Periodontal disease in pregnancy: Correlation between oral hygiene and periodontal condition. Acta Odont Scand 1964;22:112-135.
26. Löe H. The gingival index, the plaque index and the retention index system. J Periodontol 1967;38:610-616.
27. Muhlemann HR, Son S. Gingival sulcus bleeding: A leading symptom in initial gingivitis. Helvet Odontol Acta 1971;15:107-113.
28. Rattan J, Schneider M, Arber N, Gorsky M, Dayan D. Sucralfate suspension as a treatment of recurrent aphtae stomatitis. J Int Med 1994;236:341-343.
29. Tamawski A. Sucralfate. It is more than just a barrier? Cycoprotection - future direction in prevention and treatment of gastrointestinal mucosal injury. Curr Concepts Gastroenterol 1984;1:5-8.
30. th International Sucralfate Research Conference. Am J Med 1989;86:1-155.
31. Garrett WR.: Sucralfate. Alternative therapy for peptic ulcer disease. Clin Pharm 1982;1:307-314.
32. Konturek SJ, Brorowski T, Drozdowicz T, et al. Role of acid milieu in the gastroprotective and ulcer-healing activity of sucralfate. Am J Med 1991;91:205-291.
33. Brown DT, Miller CH, Maupin DE. The effect of sucralfate on the growth of cariogenic streptococci. J Prosthet Dent 1991;66:256-260.
34. Wright JT, Fine JD, Johnson L. Hereditary epidermolysis bullosa: oral manifestations and dental management. Pediatr Dent 1993;15:242-247.
35. Wright JT, Johnson LB, Fine DJ. Development defects of enamel in humans with hereditary epidermolysis bullosa. Arch Oral Biol 1993;38:945-955.
36. Wright JT, Fine DJ. Hereditary epidermolysis bullosa. Sem Dermatol 1994;13:102-107.
37. Fuchs E. Genetic skin disorders of keratin. J Invest Dermatol 1992;99:671-674.